AIP Form 144 Notifies Sale of 11,821 Shares; Prior 94,245-Share Sale Listed

Rhea-AI Filing Summary

Arteris, Inc. (AIP) filed a Form 144 notifying the proposed sale of 11,821 common shares with an aggregate market value of $133,104.46. The shares are to be sold on or about 10/03/2025 on NASDAQ.

The filing shows these shares were acquired as Restricted Stock Units from the issuer on 10/01/2025. The filer reported multiple sales in the prior three months, including sales of 94,245 shares on 08/05/2025 (gross proceeds $1,271,120.01) and other transactions on 09/02/2025, 09/04/2025, and 10/02/2025.

Insights

Securities Compliance Analyst

Form 144 notifies an intended insider sale of 11,821 shares on 10/03/2025.

The filing records that the shares to be sold were acquired as Restricted Stock Units on 10/01/2025, and the sale is to occur on NASDAQ. This notice meets Rule 144’s reporting pathway for proposed sales by persons of restricted or control securities.

The filing also discloses prior sales by the same person and related 10b5-1 activity totaling significant recent dispositions (for example, 94,245 shares sold on 08/05/2025 for $1,271,120.01), which is relevant to assessing recent insider liquidity.

Monitorable item: the approximate sale date is 10/03/2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11821	133104.46	42649917	10/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2025	Restricted Stock Units	Issuer			11821	10/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	10/02/2025	7147	78050.96
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/04/2025	2057	17948.35
K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	1246	1552516.00
10b5-1 Sales for K. CHARLES JANAC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	94245	1271120.01
10b5-1 Sales for BAYVIEW LEGACY, LLC 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	50000	655995.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arteris (AIP) Form 144 disclose?

The Form 144 discloses a proposed sale of 11,821 common shares valued at $133,104.46, to be sold on or about 10/03/2025 on NASDAQ.

When were the shares to be sold acquired for Arteris (AIP)?

The shares were acquired as Restricted Stock Units from the issuer on 10/01/2025.

Has the filer sold shares recently for Arteris (AIP)?

Yes. The filing lists multiple sales in the past three months, including 94,245 shares on 08/05/2025 (gross proceeds $1,271,120.01) and sales on 09/02/2025, 09/04/2025, and 10/02/2025.

On which exchange will the Arteris shares be sold?

The filing specifies the sale will occur on NASDAQ.

Who is identified in the prior-sales section of the Form 144?

The prior-sales section names K. CHARLES JANAC and related 10b5-1 sales, with listed addresses and transaction details.